FIND DRUGS:

BRAND NAME GENERIC NAME INDICATION MANUFACTURERS COMPARE DRUGS

Feature Articles

PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy

PD-1 Pathway Inhibitors: Changing the Landscape of Cancer Immunotherapy

Immunotherapeutic approaches to treating cancer have been evaluated during the last few decades with limited success.

Primary Androgen-Deprivation Therapy (ADT) for Localized Prostate Cancer: Potential for Harm May Outweigh Benefit in Low-Risk Disease

Primary Androgen-Deprivation Therapy (ADT) for Localized Prostate Cancer: Potential for Harm May Outweigh Benefit in Low-Risk Disease

Although ADT remains an important treatment, its use as primary therapy in low-risk prostate cancer seems increasingly ill advised.

Biomarkers of HIV-associated Cancer

Biomarkers of HIV-associated Cancer

Biomarkers can provide great opportunities in the management of the most common HIV-associated malignancies, namely, Kaposi sarcoma, non-Hodgkin's lymphoma, and invasive cervical cancer.

Oral Contraceptives and the Risk of Breast Cancer

Oral Contraceptives and the Risk of Breast Cancer

Certain oral contraceptives may increase breast cancer risk, but researchers caution that the risk is small, if it exists at all.

FDG-PET/CT in the Assessment of Treatment Response after Oncologic Treatment of Head and Neck Squamous Cell Carcinoma

FDG-PET/CT in the Assessment of Treatment Response after Oncologic Treatment of Head and Neck Squamous Cell Carcinoma

18F-fluorodeoxyglucose-positron emission tomography/computed tomography (FDG-PET/CT) is used to monitor treatment response after definitive (chemo)radiotherapy for head and neck squamous cell carcinoma, but its usefulness remains controversial.

New Therapies in T-cell Lymphoma

New Therapies in T-cell Lymphoma

Biomarker-driven chemotherapeutics is becoming a critical part of the state-of-the-art treatment in early- and late-phase clinical trials involving patients with T-cell lymphoma.

Diarrhea and Patients With Cancer

Diarrhea and Patients With Cancer

Diarrhea is a treatment symptom as common as hair loss but with deadlier implications.

Cervical Cancer Rates May Be Higher in Older Women Than Previously Reported

Cervical Cancer Rates May Be Higher in Older Women Than Previously Reported

Rate of cervical cancer in African-American women is higher than what was previously recognized.

AMEN Protocol Designed to Help Clinicians When Patients Hope for Miracles

AMEN Protocol Designed to Help Clinicians When Patients Hope for Miracles

The protocol was developed to guide clinicians who have limited medical intervention options.

No Silver Bullet for Patient Nonadherence to Oral Anticancer Therapies

No Silver Bullet for Patient Nonadherence to Oral Anticancer Therapies

Oncologists need more information on the factors that lead to nonadherence in order to actively prevent it.

Palliative Care Integration and Expertise Are Pressing Goals for Oncologists

Palliative Care Integration and Expertise Are Pressing Goals for Oncologists

There is still more work to be done to ensure that palliative care is understood.

Oncologists Asked to Play Greater Role in Helping Obese Patients With Cancer

Oncologists Asked to Play Greater Role in Helping Obese Patients With Cancer

ASCO recommendation tasks oncologists with assisting obese patients with cancer in finding appropriate resources for weight management.

Helping Patients With Cancer Avoid Financial Toxicity

Helping Patients With Cancer Avoid Financial Toxicity

Cancer care costs are becoming a significant problem; however, a new tool may help oncologists assess how patients will be affected by treatment expenses.

'Truly Personalized Medicine' Emphasizes Value—Not Cost—of Cancer Care

'Truly Personalized Medicine' Emphasizes Value—Not Cost—of Cancer Care

With the cost of cancer care rising, an ASCO task force has been established to create a framework for assessing relative value of cancer treatment.

ASCO 2014: A Fellow's Take on Posters, Presentations, and the Magnificent Mile

ASCO 2014: A Fellow's Take on Posters, Presentations, and the Magnificent Mile

Muhammad Rizvi, MD, discusses lung cancer research from ASCO 2014.

Sign Up for Free e-newsletters

CTA Community Poll

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs